Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a reality in clinical development pipelines. In spring 2024, CBER reported more ...
The MarketWatch News Department was not involved in the creation of this content. New ProfAI agent transforms every employee into an AI power user by delivering personalized, role-specific use cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback